These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11745926)

  • 1. Influenza vaccination of HIV-1-positive and HIV-1-negative former intravenous drug users.
    Amendola A; Boschini A; Colzani D; Anselmi G; Oltolina A; Zucconi R; Begnini M; Besana S; Tanzi E; Zanetti AR
    J Med Virol; 2001 Dec; 65(4):644-8. PubMed ID: 11745926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
    Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users.
    Amendola A; Tanzi E; Zappa A; Colzani D; Boschini A; Musher DM; Zanetti AR
    Vaccine; 2002 Nov; 20(31-32):3720-4. PubMed ID: 12399200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users.
    Iorio AM; Alatri A; Francisci D; Preziosi R; Neri M; Donatelli I; Castrucci MR; Biasio LR; Tascini C; Iapoce R; Pierucci P; Baldelli F
    Vaccine; 1997 Jan; 15(1):97-102. PubMed ID: 9041673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.
    Günthard HF; Wong JK; Spina CA; Ignacio C; Kwok S; Christopherson C; Hwang J; Haubrich R; Havlir D; Richman DD
    J Infect Dis; 2000 Feb; 181(2):522-31. PubMed ID: 10669335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of activation-induced deaminase (AID) expression with antibody response to A(H1N1)pdm09 vaccination in HIV-1 infected patients.
    Cagigi A; Pensieroso S; Ruffin N; Sammicheli S; Thorstensson R; Pan-Hammarström Q; Hejdeman B; Nilsson A; Chiodi F
    Vaccine; 2013 Apr; 31(18):2231-7. PubMed ID: 23499520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response.
    Fuller JD; Craven DE; Steger KA; Cox N; Heeren TC; Chernoff D
    Clin Infect Dis; 1999 Mar; 28(3):541-7. PubMed ID: 10194075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.
    Rinaldi S; Zangari P; Cotugno N; Manno EC; Brolatti N; Castrucci MR; Donatelli I; Rossi P; Palma P; Cagigi A
    Vaccine; 2014 Feb; 32(6):657-63. PubMed ID: 24333344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial.
    McKittrick N; Frank I; Jacobson JM; White CJ; Kim D; Kappes R; DiGiorgio C; Kenney T; Boyer J; Tebas P
    Ann Intern Med; 2013 Jan; 158(1):19-26. PubMed ID: 23277897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compromised B cell responses to influenza vaccination in HIV-infected individuals.
    Malaspina A; Moir S; Orsega SM; Vasquez J; Miller NJ; Donoghue ET; Kottilil S; Gezmu M; Follmann D; Vodeiko GM; Levandowski RA; Mican JM; Fauci AS
    J Infect Dis; 2005 May; 191(9):1442-50. PubMed ID: 15809902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.
    Montoya CJ; Toro MF; Aguirre C; Bustamante A; Hernandez M; Arango LP; Echeverry M; Arango AE; Prada MC; Alarcon Hdel P; Rojas M
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):501-8. PubMed ID: 17612772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes.
    Kroon FP; van Dissel JT; de Jong JC; van Furth R
    AIDS; 1994 Apr; 8(4):469-76. PubMed ID: 7912086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients.
    Fowke KR; D'Amico R; Chernoff DN; Pottage JC; Benson CA; Sha BE; Kessler HA; Landay AL; Shearer GM
    AIDS; 1997 Jul; 11(8):1013-21. PubMed ID: 9223736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced immune response to influenza A (H1N1) 2009 monovalent vaccine in HIV-infected Japanese subjects.
    Yanagisawa N; Maeda K; Ajisawa A; Imamura A; Suganuma A; Ando M; Takayama N; Okuno Y
    Vaccine; 2011 Aug; 29(34):5694-8. PubMed ID: 21689709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy.
    Kroon FP; Rimmelzwaan GF; Roos MT; Osterhaus AD; Hamann D; Miedema F; van Dissel JT
    AIDS; 1998 Dec; 12(17):F217-23. PubMed ID: 9863863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
    Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
    J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals.
    Tebas P; Frank I; Lewis M; Quinn J; Zifchak L; Thomas A; Kenney T; Kappes R; Wagner W; Maffei K; Sullivan K;
    AIDS; 2010 Sep; 24(14):2187-92. PubMed ID: 20616698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects.
    Pinto LA; Blazevic V; Anderson SA; Venzon DJ; Trubey CM; Rowe T; Katz JM; Liewehr D; Dolan MJ; Shearer GM
    J Infect Dis; 2001 Apr; 183(7):1000-8. PubMed ID: 11237823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term seroprotective response of trivalent seasonal influenza vaccine in HIV-infected children, regardless of immunogenicity before immunisation.
    Moolasart V; Manosuthi W; Ausavapipit J; Chottanapund S; Likanonsakul S; Uttayamakul S; Srisopha S; Lerdsamran H; Puthavathana P
    Int J STD AIDS; 2016 Aug; 27(9):761-8. PubMed ID: 26138900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.